| Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome. | |
| | |
MedLine Citation:
|
PMID: 21411081 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
The aim of this retrospective study is to investigate the frequency and severity of ovarian hyperstimulation syndrome and the pregnancy rate in a patient collective at risk who received bromocriptine treatment. |
| | |
Authors:
|
Dietmar Spitzer; Johannes Wogatzky; Maximilian Murtinger; Mathias H Zech; Robert Haidbauer; Nicolas H Zech |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-3-14 |
Journal Detail:
|
Title: Fertility and sterility Volume: - ISSN: 1556-5653 ISO Abbreviation: - Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-3-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372772 Medline TA: Fertil Steril Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved. |
Affiliation:
|
IVF Centers Prof. Zech, Salzburg, Austria. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The frozen embryo and its nonresponding parents.
Next Document: Unique uterine localization and regulation may differentiate LPA3 from other lysophospholipid recept...